Allspring Global Investments Holdings LLC Cuts Stake in Veradigm Inc. (NASDAQ:MDRX)

Allspring Global Investments Holdings LLC cut its stake in Veradigm Inc. (NASDAQ:MDRX) by 26.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,031 shares of the software maker’s stock after selling 3,209 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Veradigm were worth $95,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of MDRX. Covestor Ltd raised its position in shares of Veradigm by 10.3% in the third quarter. Covestor Ltd now owns 10,336 shares of the software maker’s stock valued at $136,000 after buying an additional 966 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in Veradigm in the 3rd quarter valued at about $189,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Veradigm by 8.1% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 20,068 shares of the software maker’s stock worth $264,000 after purchasing an additional 1,507 shares in the last quarter. Orion Portfolio Solutions LLC acquired a new position in shares of Veradigm during the 3rd quarter worth approximately $313,000. Finally, AXQ Capital LP purchased a new stake in shares of Veradigm in the third quarter valued at approximately $339,000.

Veradigm Stock Up 0.3 %

NASDAQ MDRX opened at $7.98 on Tuesday. The firm’s 50-day moving average is $7.74 and its two-hundred day moving average is $9.82. Veradigm Inc. has a 12 month low of $5.01 and a 12 month high of $14.09.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. StockNews.com initiated coverage on Veradigm in a research report on Tuesday, April 23rd. They set a “hold” rating on the stock. Royal Bank of Canada lowered their price target on shares of Veradigm from $22.00 to $11.00 and set an “outperform” rating on the stock in a research report on Friday, January 19th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $10.00 price objective (down from $15.00) on shares of Veradigm in a research report on Tuesday, March 19th. Finally, Barclays initiated coverage on shares of Veradigm in a report on Wednesday, January 3rd. They issued an “equal weight” rating and a $11.00 target price on the stock. Five analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Veradigm has a consensus rating of “Hold” and an average price target of $11.25.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.